The Current Ratio as of September 2024 (TTM) for Chinook Therapeutics, Inc. (KDNY) is 5.82

According to Chinook Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.82. This represents a change of -19.65% compared to the average of 7.24 of the last 4 quarters.

Chinook Therapeutics, Inc. (KDNY) Historical Current Ratio (quarterly & annually)

How has KDNY Current Ratio performed in the past?

The mean historical Current Ratio of Chinook Therapeutics, Inc. over the last ten years is 9.30. The current 5.82 Current Ratio has changed 6.16% with respect to the historical average. Over the past ten years (40 quarters), KDNY's Current Ratio was at its highest in in the June 2015 quarter at 14.74. The Current Ratio was at its lowest in in the March 2015 quarter at 3.36.

Chinook Therapeutics, Inc. (KDNY) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Chinook Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Chinook Therapeutics, Inc. (KDNY) Average Current Ratio

How has KDNY Current Ratio performed in the past?

The current Current Ratio of Chinook Therapeutics, Inc. (KDNY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Chinook Therapeutics, Inc. (KDNY) Current Ratio vs. Peers

How is KDNY’s Current Ratio compared to its peers?

Chinook Therapeutics, Inc.’s Current Ratio is less than DICE Therapeutics, Inc. (25.88), less than Pliant Therapeutics, Inc. (14.47), less than Crinetics Pharmaceuticals, Inc. (16.09), greater than Ascendis Pharma A/S (0.74), less than Ventyx Biosciences, Inc. (14.19), less than Nuvalent, Inc. (17.44), less than Cerevel Therapeutics Holdings, Inc. (10.22), greater than Travere Therapeutics, Inc. (3.04), less than Structure Therapeutics Inc. (41.38), less than Avidity Biosciences, Inc. (15.78), less than Revolution Medicines, Inc. (15.42), greater than Day One Biopharmaceuticals, Inc. (4.09), less than SpringWorks Therapeutics, Inc. (7.91), less than Arcellx, Inc. (6.01), less than Vaxcyte, Inc. (17.88), less than Viridian Therapeutics, Inc. (15.82), less than KalVista Pharmaceuticals, Inc. (8.55), less than Theseus Pharmaceuticals, Inc. (29.93), less than Kura Oncology, Inc. (14.94),

Build a custom stock screener for Chinook Therapeutics, Inc. (KDNY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chinook Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chinook Therapeutics, Inc. (KDNY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chinook Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.